These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1677052)

  • 21. [Endocrine APUD cells in papillary-follicular thyroid cancer with stromal amyloidosis].
    Lomakina II; Serezhin BS; Nikonov AA
    Arkh Patol; 1981; 43(11):71-4. PubMed ID: 6119069
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of islet amyloid in type 2 diabetes mellitus: consequence or cause?
    Höppener JW; Nieuwenhuis MG; Vroom TM; Ahrén B; Lips CJ
    Mol Cell Endocrinol; 2002 Nov; 197(1-2):205-12. PubMed ID: 12431814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Insulin-deprived NIDDM].
    Kobayashi T
    Nihon Rinsho; 1997 Nov; 55 Suppl():608-11. PubMed ID: 9434536
    [No Abstract]   [Full Text] [Related]  

  • 24. An in vitro model of early islet amyloid polypeptide (IAPP) fibrillogenesis using human IAPP-transgenic mouse islets.
    Henson MS; Buman BL; Jordan K; Rahrmann EP; Hardy RM; Johnson KH; O'Brien TD
    Amyloid; 2006 Dec; 13(4):250-9. PubMed ID: 17107885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Up-regulated pancreatic tissue microRNA-375 associates with human type 2 diabetes through beta-cell deficit and islet amyloid deposition.
    Zhao H; Guan J; Lee HM; Sui Y; He L; Siu JJ; Tse PP; Tong PC; Lai FM; Chan JC
    Pancreas; 2010 Aug; 39(6):843-6. PubMed ID: 20467341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Senile, hereditary and local amyloidosis].
    Vinogradova OM; Kochubeĭ LN; Serov VV; Vasil'eva NA; Tomas NIu
    Klin Med (Mosk); 1988 Aug; 66(8):16-27. PubMed ID: 2903943
    [No Abstract]   [Full Text] [Related]  

  • 27. Islet pathology of non-insulin-dependent diabetes mellitus (NIDDM).
    Westermark P
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S46-8. PubMed ID: 8894481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged exposure of pancreatic beta cells to raised glucose concentrations results in increased cellular content of islet amyloid polypeptide precursors.
    Hou X; Ling Z; Quartier E; Foriers A; Schuit F; Pipeleers D; Van Schravendijk C
    Diabetologia; 1999 Feb; 42(2):188-94. PubMed ID: 10064099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formation of islet amyloid from islet amyloid polypeptide.
    Clark A; de Koning EJ; Morris JF
    Biochem Soc Trans; 1993 Feb; 21(1):169-73. PubMed ID: 8449286
    [No Abstract]   [Full Text] [Related]  

  • 30. [Role of IAPP in the pathogenesis and development of NIDDM].
    Sanke T; Nishi M; Nanjo K
    Nihon Rinsho; 1994 Oct; 52(10):2737-45. PubMed ID: 7983807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the small tyrosine kinase inhibitor Imatinib mesylate counteract diabetes by affecting pancreatic islet amyloidosis and fibrosis?
    Welsh N
    Expert Opin Investig Drugs; 2012 Nov; 21(11):1743-50. PubMed ID: 22998750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of islet amyloid in type 2 diabetes mellitus.
    Höppener JW; Lips CJ
    Int J Biochem Cell Biol; 2006; 38(5-6):726-36. PubMed ID: 16459127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Islet amyloid polypeptide and diabetes mellitus].
    Nakazato M; Matsukura S
    Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1435-8. PubMed ID: 8245641
    [No Abstract]   [Full Text] [Related]  

  • 34. Copper-mediated formation of hydrogen peroxide from the amylin peptide: a novel mechanism for degeneration of islet cells in type-2 diabetes mellitus?
    Masad A; Hayes L; Tabner BJ; Turnbull S; Cooper LJ; Fullwood NJ; German MJ; Kametani F; El-Agnaf OM; Allsop D
    FEBS Lett; 2007 Jul; 581(18):3489-93. PubMed ID: 17617411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloidosis and diabetes in humans.
    Melato M; Antonutto G; Falconieri G
    Pathol Res Pract; 1980 Dec; 170(1-3):1-23. PubMed ID: 18788149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Islet amyloid and type 2 diabetes.
    Clark A
    Diabet Med; 1989; 6(7):561-7. PubMed ID: 2527693
    [No Abstract]   [Full Text] [Related]  

  • 37. Islet amyloid polypeptide: mechanisms of amyloidogenesis in the pancreatic islets and potential roles in diabetes mellitus.
    Johnson KH; O'Brien TD; Betsholtz C; Westermark P
    Lab Invest; 1992 May; 66(5):522-35. PubMed ID: 1573849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The occurrence of islet amyloid polypeptide amyloidosis in Japanese subjects.
    Su Y; Misumi Y; Ueda M; Shono M; Tasaki M; Guo J; Jono H; Obayashi K; Senokuchi T; Yamagata K; Ando Y
    Pancreas; 2012 Aug; 41(6):971-3. PubMed ID: 22781911
    [No Abstract]   [Full Text] [Related]  

  • 39. Pancreatic ganglioneuronal amyloid. Occurrence in diabetic cats with islet amyloidosis.
    O'Brien TD; Johnson KH; Hayden DW
    Am J Pathol; 1985 Jun; 119(3):430-5. PubMed ID: 2409805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Islet amyloid polypeptide inserts into phospholipid monolayers as monomer.
    Engel MF; Yigittop H; Elgersma RC; Rijkers DT; Liskamp RM; de Kruijff B; Höppener JW; Antoinette Killian J
    J Mol Biol; 2006 Feb; 356(3):783-9. PubMed ID: 16403520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.